Cardiac Effects in Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00903890|
Recruitment Status : Active, not recruiting
First Posted : May 19, 2009
Last Update Posted : January 9, 2018
|Condition or disease||Intervention/treatment|
|Hodgkin Disease Lymphoma, Non-Hodgkin||Other: Survey|
|Study Type :||Observational|
|Actual Enrollment :||32 participants|
|Official Title:||Cardiac Effects in Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma After Radiation Therapy/Anthracycline Chemotherapy|
|Study Start Date :||August 2008|
|Estimated Primary Completion Date :||November 2018|
|Estimated Study Completion Date :||December 2018|
Individuals who have previously received radiation therapy and anthracycline chemotherapy for their Hodgkin's or non-Hodgkin's lymphoma.
Survey asking questions regarding the subjects cardiac and general health.
- Measure changes in Cardiac ejection fraction score [ Time Frame: Post Radiation Treatment ]
- Measure changes in perfusion imaging score on the radionuclide cardiac profusion scan [ Time Frame: Post Radiation ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00903890
|United States, New York|
|University of Rochester Medical Center|
|Rochester, New York, United States, 14642|
|Principal Investigator:||Louis S Constine, MD||University of Rochester|